Pfizer receives CHMP positive opinion for novel COVID-19 oral treatment
Summary : Pfizer Inc. (NYSE: PFE) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
Summary : Pfizer Inc. (NYSE: PFE) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
Synopsis : ViiV Healthcare’s HIV treatment Cabenuva has been approved by the U.S. Food and Drug Administration for use every two months,…
Summary : Pfizer and Ionis Pharmaceuticals announced that the former is abandoning its vupanorsen program for cardiovascular (CV) risk reduction and severe…
Synopsis : Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases, announced today that Dr. Dominic F.…
Executive Summary The pharma also warns that an FDA complete response letter could be coming for its supplemental NDA to add atopic…
Summary : EMA’s human medicines committe has recommended granting conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 / ritonavir) for…
Synopsis: Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat…
Summary : Xebra Brands Ltd. , a cannabis company, is pleased to announce that it has satisfied all conditions pursuant to its…
Summary : Today, Cellino Biotech , an autonomous cell therapy manufacturing company, announced an $80 million Series A financing round led by…
Synopsis : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the initiation of a clinical study to evaluate the safety,…